Targeting BRD8 bromodomain displaces H2AZ, making chromatin accessible for p53 activation, leading to cell cycle arrest and tumor suppression, presenting a potential therapeutic avenue for p53 wt GBM [53]. The gene discussed is TP53; the disease is glioblastoma.